The present study demonstrates that low expression of LRP1 is a major contributor to the invasion-prone phenotype of HCC, and inhibition of LRP1, coupled to the increased expression and bioactivity of MMP9, enhances tumor cell migration and invasion. This evidence concerns the gene LRP1 and hepatocellular carcinoma.